These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23217078)

  • 1. Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine.
    Wang X; Ward PA
    J Transl Med; 2012 Dec; 10():240. PubMed ID: 23217078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine.
    Wang X; Ward PA
    J Transl Med; 2012 Nov; 10():220. PubMed ID: 23134706
    [No Abstract]   [Full Text] [Related]  

  • 3. Translational biomarkers: from discovery and development to clinical practice.
    Subramanyam M; Goyal J
    Drug Discov Today Technol; 2016; 21-22():3-10. PubMed ID: 27978985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.
    Visser SAG; Bueters TJH
    Eur J Pharm Sci; 2017 Nov; 109S():S72-S77. PubMed ID: 28811131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers.
    Day M; Rutkowski JL; Feuerstein GZ
    Adv Exp Med Biol; 2009; 655():1-12. PubMed ID: 20047030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotopic biomarker discovery and application in translational medicine.
    Bayele HK; Chiti A; Colina R; Fernandes O; Khan B; Krishnamoorthy R; Ozdağ H; Padua RA
    Drug Discov Today; 2010 Feb; 15(3-4):127-36. PubMed ID: 20038454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing the cancer microenvironment section of Journal of Translational Medicine.
    Vidal-Vanaclocha F; Witz IP
    J Transl Med; 2010 Jun; 8():60. PubMed ID: 20569469
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing the nutrition & metabolism section of Journal of Translational Medicine.
    Soldati L; Dogliotti E; Camera I; Terranegra A
    J Transl Med; 2012 Jan; 10():17. PubMed ID: 22289680
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers, Translational Medicine, and Drug Development: An Interview with Chirag R. Parikh, MD, PhD.
    Horien C
    Yale J Biol Med; 2017 Mar; 90(1):153-156. PubMed ID: 28356903
    [No Abstract]   [Full Text] [Related]  

  • 11. The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?
    Horii I
    J Toxicol Sci; 2016; 41(Special):SP49-SP67. PubMed ID: 28250284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.
    Khalili-Mahani N; Rombouts SA; van Osch MJ; Duff EP; Carbonell F; Nickerson LD; Becerra L; Dahan A; Evans AC; Soucy JP; Wise R; Zijdenbos AP; van Gerven JM
    Hum Brain Mapp; 2017 Apr; 38(4):2276-2325. PubMed ID: 28145075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of New Journal Section-Translational Medicine.
    Malley R
    Pediatr Infect Dis J; 2018 Nov; 37(11):1175. PubMed ID: 30153234
    [No Abstract]   [Full Text] [Related]  

  • 16. Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward.
    Roberts RA; Aschner M; Calligaro D; Guilarte TR; Hanig JP; Herr DW; Hudzik TJ; Jeromin A; Kallman MJ; Liachenko S; Lynch JJ; Miller DB; Moser VC; O'Callaghan JP; Slikker W; Paule MG
    Toxicol Sci; 2015 Dec; 148(2):332-40. PubMed ID: 26609132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.
    Wan HI; Jacobsen JS; Rutkowski JL; Feuerstein GZ
    Clin Transl Sci; 2009 Jun; 2(3):242-7. PubMed ID: 20443898
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal NO as a biomarker: don't say NO to the many challenges of translational medicine.
    Voynow JA; Montpetit AJ
    Pediatr Pulmonol; 2015 Jan; 50(1):100-2. PubMed ID: 25310962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bedside to bench and back: Translating ASD models.
    Drozd HP; Karathanasis SF; Molosh AI; Lukkes JL; Clapp DW; Shekhar A
    Prog Brain Res; 2018; 241():113-158. PubMed ID: 30447753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.
    Qian F; Guo J; Jiang Z; Shen B
    Int J Biol Sci; 2018; 14(8):920-929. PubMed ID: 29989102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.